• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION UNKNOWN IMPLANTABLE NEUROSTIMULATOR; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION UNKNOWN IMPLANTABLE NEUROSTIMULATOR; IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS) Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Connection Problem (2900)
Patient Problems Wound Dehiscence (1154); Unspecified Infection (1930); Complaint, Ill-Defined (2331)
Event Date 05/06/2015
Event Type  Injury  
Event Description
Rizzi, m., messina, g., penner, f., d'ammando, a., muratorio, f., franzini, a.Internal pulse generators in deep brain stimulation: rechargeable or not? an economical study.World neurosurgery.2015 may 30.Summary: deep brain stimulation (dbs) is a cost-effective strategy for the treatment of different neurological disorders.Nevertheless dbs procedures are burdened by the high costs of implantation and internal pulse generator (ipg) replacement.Different companies propose the use of rechargeable ipgs (rc-ipgs).The aim of our study is to compare the implantation costs of non-rc ipgs versus the estimated costs of rc-ipgs, in order to evaluate if an economical advantage for the health system could derive, in different categories of patients.One hundred and forty nine patients who underwent surgical procedure of ipg substitution were considered.A hypothetic scenario was realized in which the rechargeable ipgs were implanted instead of non-rc ipgs, at the time of dbs system implantation.Moreover, another scenario was outlined in a perspective period of time, corresponding to the patients' life-expectancy.Costs were calculated and inferential analysis performed.Results a savings of (b)(4), including the cost of complications management, was calculated during follow-up period of 7,9 years.In a comprehensive life-expectancy period of 47 years, a saving of (b)(4) would have been obtained (p <(><<)>0.05).Long-term groups data points out that a relevant savings would be expected from rc-ipgs implantation in the dystonic patients (p<(><<)>0.05), in patients with parkinson's disease (p<(> <<)>0.05) and it is projected to occur also in other categories of patients (p<(><<)>0.05).Rc-ipgs implantation presents different clinical advantages, if compared to non-rc devices.Huge economical resources can be spared with the implantation of rc ipgs, in categories of patients implanted with dbs.Reported event(s): 1.2 patients with deep brain stimulation (dbs) for dystonia experienced complications following a non-rechargeable single channel implantable neurostimulator (ins) replacement.It was noted that these complications were ascribable to the ins substitution (ie erroneous connection of the extension cable to the ins and wound dehiscence with or without demonstrated infection).The source literature included the following device specifics: soletra, kinetra, activa sc and activa pc further information has been requested; a supplemental report will be submitted if additional information is received.
 
Manufacturer Narrative
It was not possible to ascertain specific device information from the article or to match the events reported with previously reported events.Correspondence has been sent to the author of the article inquiring about individual patient information and additional information regarding the reported events.Concomitant products: product id neu_ins_stimulator, lot # unknown, product type implantable neurostimulator; product id neu_unknown_lead, lot # unknown, product type lead.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN IMPLANTABLE NEUROSTIMULATOR
Type of Device
IMPLANTED SUBCORTICAL ELECTRICAL STIMULATOR (MOTOR DISORDERS)
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 120
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
7000 central avenue ne rcw215
minneapolis MN 55432
Manufacturer Contact
diane wolf
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263987
MDR Report Key4950075
MDR Text Key17312477
Report Number3007566237-2015-02133
Device Sequence Number1
Product Code MRU
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
H020007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Health Professional
Type of Report Initial
Report Date 07/01/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/29/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00013 YR
-
-